Pernix Therapeutics Special Purpose Vehicle Has Been Informed By Orexigen That No Other Bids For Orexigen's Assets Were Received By Bid Deadline, Will Acquire Worldwide Rights To Contrave For $75M Cash
Benzinga Newsdesk